Announced Tue, 30 Sept · 16:05 IST

29th Annual General Meeting of Deccan Health Care Limited held through VC on 30th September, 2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Deccan Health Care Ltd held its 29th Annual General Meeting on September 30, 2025 via video conferencing, running from 3:00 PM to 3:32 PM IST, with 17 members in attendance. The meeting was chaired by Dr. Minto Purshotam Gupta (Chairman & Managing Director), with all five directors present along with the Company Secretary, statutory auditors, and the scrutinizer. The Chairman reviewed FY 2024-25 performance, reporting sales of ₹7,513.76 Lakhs (a 25% increase over the previous year) and a Net Profit After Tax of ₹119.79 Lakhs. The company reinvented 18 nutraceutical products during the year, highlighted growth of its B2C/B2B platform beYoungStore, and outlined plans to tap into the ₹40 lakh crore global nutraceutical market (7-9% CAGR) through product registrations, clinical validations, and export expansion. All speaker queries were addressed by the Chairman. The consolidated e-voting results and scrutinizer's report will be submitted to BSE separately in due course.

Likely market impact

This is a routine procedural filing confirming the AGM was conducted in compliance with regulations; no immediate stock-moving action. The disclosed 25% sales growth and modest PAT of ₹119.79 Lakhs suggest steady but thin-margin momentum. Investors should watch for the separate e-voting results filing, which will confirm shareholder approval of the resolutions.